EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.5.3.1 | Acute Kidney Injury |
16825094 |
Melatonin reduces nitric oxide via increasing arginase in rhabdomyolysis-induced acute renal failure in rats. |
causal interaction ongoing research unassigned |
2 3 0 |
3.5.3.1 | Acute Lung Injury |
20938379 |
Acute Lung Injury-Induced Collagen Deposition is Associated with Elevated Asymmetric Dimethylarginine and Arginase Activity. |
causal interaction diagnostic usage unassigned |
4 3 0 |
3.5.3.1 | Acute Lung Injury |
23966993 |
Arginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 1 1 |
3.5.3.1 | Adenocarcinoma |
1643605 |
Clinical significance of arginase in colorectal cancer. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 2 0 |
3.5.3.1 | Adenocarcinoma |
8797936 |
Immunohistochemical study of arginase in cancer of the stomach. |
causal interaction diagnostic usage ongoing research unassigned |
4 3 4 0 |
3.5.3.1 | Adenocarcinoma |
11249934 |
Arginase isoforms in human colorectal cancer. |
causal interaction diagnostic usage ongoing research unassigned |
1 4 4 0 |
3.5.3.1 | Adenocarcinoma |
12011984 |
Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines. |
causal interaction ongoing research therapeutic application unassigned |
1 3 2 0 |
3.5.3.1 | Adenocarcinoma |
16935537 |
Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines. |
causal interaction ongoing research unassigned |
4 1 0 |
3.5.3.1 | Adenocarcinoma |
22848265 |
Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 2 1 |
3.5.3.1 | Adenocarcinoma |
24281232 |
Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma. |
causal interaction diagnostic usage unassigned |
2 3 0 |